Controlled trial of risperidone and divalproex sodium [valproate semisodium] with MRI assessment of affected circuitry in pre and post treatment in pediatric bipolar

Trial Profile

Controlled trial of risperidone and divalproex sodium [valproate semisodium] with MRI assessment of affected circuitry in pre and post treatment in pediatric bipolar

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2015

At a glance

  • Drugs Risperidone (Primary) ; Valproate semisodium (Primary)
  • Indications Bipolar disorders
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 01 Feb 2012 Results published in the Journal of the American Academy of Child and Adolescent Psychiatry.
    • 15 Jan 2012 Results published in Behavioural Brain Research.
    • 10 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top